Rebecca DeSensi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Rebecca DeSensi has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Ajay Darsh Wasan
Department of Anesthesiology and Perioperative Medicine, Center for Innovation in Pain Care, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
3 shared publications - Benedict J. Alter
Department of Anesthesiology and Perioperative Medicine, Division of Pain Medicine, University of Pittsburgh Medical Center , Pittsburgh, PA
3 shared publications Brian O’COnnell
Department of Anesthesiology and Perioperative Medicine, Division of Pain Medicine, University of Pittsburgh Medical Center , Pittsburgh, PA
3 shared publicationsAjay D. Wasan
Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania
1 shared publicationAndrew Watson
Department of Surgery, University of Pittsburgh , Pittsburgh, PA
1 shared publicationBrian O’cOnnell
1 shared publication
Latest Publications
- 8 October 2026
- Published by Oxford University Press (OUP) in Pain Medicine
Minimal clinically important differences in pain extent on self-reported body maps
- 8 October 2026
- Published by Oxford University Press (OUP) in Pain Medicine
Minimal clinically important differences in pain extent on self-reported body maps
- 3 March 2026
- Published by BMJ in Regional Anesthesia & Pain Medicine
Impact of ketamine infusions on healthcare utilization and chronic pain: a comparative effectiveness study with insights from real-world data
Background Previous studies provide conflicting evidence for ketamine’s effectiveness in treating chronic pain, in the context of limited real-world evidence to augment clinical trial findings. We conducted a comparative effectiveness study with real-world data to assess the impact of ketamine infusions on pain-related healthcare utilization, to bridge the gap between clinical trials and real-life care. Methods We identified 118 subjects who received intravenous (IV) ketamine infusions for chronic pain between 2018 and 2022. Using the University of Pittsburgh’s patient outcomes repository for treatment registry, we created a propensity score-matched control cohort of 118 subjects. Real-world data from the University of Pittsburgh Medical Center healthcare network was analyzed to compare unexpected pain-related healthcare utilization, including emergency room visits, urgent care visits, and hospital admissions. Utilization was assessed 6 months before and after ketamine infusion and compared with the matched control cohort. Results The ketamine cohort demonstrated a decrease in unexpected healthcare utilization 6 months after treatment compared with 6 months prior, while the control cohort showed an increase during the same period. Ketamine treatment was associated with a 45% reduction in pain-related visits compared with the control cohort (pConclusions IV ketamine was more effective than conventional therapy in reducing unexpected pain-related healthcare utilization for over 6 months in patients with chronic pain. Our study highlights the value of using real-world data and comparative effectiveness research to supplement clinical trials and enhance our understanding of the possible effects of outpatient ketamine infusion therapy.
- 3 March 2026
- Published by BMJ in Regional Anesthesia & Pain Medicine
Impact of ketamine infusions on healthcare utilization and chronic pain: a comparative effectiveness study with insights from real-world data
Background Previous studies provide conflicting evidence for ketamine’s effectiveness in treating chronic pain, in the context of limited real-world evidence to augment clinical trial findings. We conducted a comparative effectiveness study with real-world data to assess the impact of ketamine infusions on pain-related healthcare utilization, to bridge the gap between clinical trials and real-life care. Methods We identified 118 subjects who received intravenous (IV) ketamine infusions for chronic pain between 2018 and 2022. Using the University of Pittsburgh’s patient outcomes repository for treatment registry, we created a propensity score-matched control cohort of 118 subjects. Real-world data from the University of Pittsburgh Medical Center healthcare network was analyzed to compare unexpected pain-related healthcare utilization, including emergency room visits, urgent care visits, and hospital admissions. Utilization was assessed 6 months before and after ketamine infusion and compared with the matched control cohort. Results The ketamine cohort demonstrated a decrease in unexpected healthcare utilization 6 months after treatment compared with 6 months prior, while the control cohort showed an increase during the same period. Ketamine treatment was associated with a 45% reduction in pain-related visits compared with the control cohort (pConclusions IV ketamine was more effective than conventional therapy in reducing unexpected pain-related healthcare utilization for over 6 months in patients with chronic pain. Our study highlights the value of using real-world data and comparative effectiveness research to supplement clinical trials and enhance our understanding of the possible effects of outpatient ketamine infusion therapy.
- 15 September 2025
- Published by Oxford University Press (OUP) in Pain Medicine
- Vol. 27 (3) , 374-375
If you build it, they might come: Lessons learned from the development of a digital intervention for chronic pain
- 15 September 2025
- Published by Oxford University Press (OUP) in Pain Medicine
- Vol. 27 (3) , 374-375
If you build it, they might come: Lessons learned from the development of a digital intervention for chronic pain
- 12 February 2024
- Published by Elsevier in The Journal of Pain
- Vol. 25 (7) , 104489
Hierarchical Clustering Applied to Chronic Pain Drawings Identifies Undiagnosed Fibromyalgia: Implications for Busy Clinical Practice
- 12 February 2024
- Published by Elsevier in The Journal of Pain
- Vol. 25 (7) , 104489
Hierarchical Clustering Applied to Chronic Pain Drawings Identifies Undiagnosed Fibromyalgia: Implications for Busy Clinical Practice